Dr. Konstam has served as our chief scientific officer since CCS’ founding in 1997, bringing over 30 years’ experience in clinical research to his role. He is currently chief physician executive of the Cardiovascular Center at Tufts Medical Center and professor of medicine at Tufts University School of Medicine. Dr. Konstam combines vast regulatory experience on FDA advisory committees with leadership in both industry and academic clinical research.
As chief physician executive of the Cardiovascular Center, Dr. Konstam directs all of Tufts Medical Center’s programs in cardiovascular diseases. He has served as a member of the Cardiovascular and Renal Advisory Panel of the Food and Drug Administration and has consulted for the Centers for Medicare and Medicaid Services as a member of the Medicare Coverage Advisory Committee and in their programs for improving quality of care in heart failure. His principal clinical interest is heart failure, and his principal areas of investigation are ventricular remodeling in heart failure, novel pharmaceutical and device treatment for heart failure, and strategies for improving quality of cardiovascular care.